Am I Ovulating? Clomid vs. Letrozole for Ovulation Induction

Anovulation causes 20% of female infertility. Clomiphene citrate (Clomid) induces ovulation but can cause a thin endometrium and emotional side effects. Letrozole (Femara) is a more effective alternative with fewer adverse effects, offering similar success rates.

Key Takeaways

Clomid vs. Letrozole: Benefits and Risks for Ovulation Induction

Clomiphene citrate (Clomid) induces ovulation by blocking estrogen receptors but may cause a thin endometrium and thick cervical mucus. Letrozole (Femara), an aromatase inhibitor, avoids these side effects and is associated with higher pregnancy success rates (17%-19% per cycle) due to improved hormonal balance and fewer emotional side effects.

Understanding Ovulation Induction Success Rates vs. IVF

Ovulation induction has a 17%-19% per-cycle pregnancy success rate, lower than IVF’s 50% rate. However, it is more cost-effective and carries a higher risk of multiple pregnancies compared to IVF centers practicing elective single embryo transfer.

Age Considerations for Ovulation Induction in Women Under 35

Women under 35 with no other infertility factors should consider ovulation induction (max 3 cycles) as a first-line treatment. For women over 35, IVF is often more cost-effective despite similar success rates, due to prolonged treatment costs and lower cumulative outcomes with induction.

Maximizing Ovulation Induction: Limiting to 3 Cycles

No more than three ovulation induction cycles should be attempted due to diminishing returns and the competitive cost-per-pregnancy of IVF in specialized centers. This is particularly critical for women over 35 or those with unexplained infertility.

When to Transition from Ovulation Induction to IVF

If ovulation induction fails after three cycles or if a patient is over 35, transitioning to IVF is recommended. IVF offers higher success rates (50%) and better control over implantation risks, especially for women with age-related fertility decline.

Source: Read full article